|
28 Feb 2007 |
Human Genome Sciences Initiates Phase 3 Clinical Trial Of Albuferon(R) With Ribavirin In Treatment-Naïve Patients With Chronic Hepatitis C Genotypes 2 And 3
|
|
27 Feb 2007 |
Bristol-Myers Squibb Company and Adnexus Therapeutics Announce Collaboration to Develop and Commercialize Innovative Oncology Compounds
|
|
27 Feb 2007 |
Phase 3 stroke trial shows that NovoSeven® reduces bleeding in the brain, but does not improve long-term clinical outcomes
|
|
27 Feb 2007 |
Lilly Plans New Clinical Trial of Xigris
|
|
27 Feb 2007 |
Ipsen Grants Galderma Exclusive Rights to Develop, Promote and Distribute Its Botulinum Toxin Type A Product for Aesthetic Indications in Europe and Certain Other Territories
|
|
26 Feb 2007 |
TOP Classes of Biologics with 2006 Sales of US$ 63.8 bln
|
|
24 Feb 2007 |
Recruitment temporarily suspended into C.E.R.A. Phase II oncology trial
|
|
22 Feb 2007 |
Breakthrough oral delivery for arthritis sufferers
|
|
22 Feb 2007 |
BioMimetic Therapeutics Receives Orphan Drug Designation for rhPDGF-BB Treatment of Osteonecrosis of the Jaw
|
|
22 Feb 2007 |
Allon files IND for approval of Schizophrenia Phase II clinical trials
|
|
21 Feb 2007 |
Auxilium Announces Results from Phase III Trial that Show AA4500 Successful in Treating Dupuytren's Contracture
|
|
21 Feb 2007 |
Bentley Announces Approval and Expansion of Its Nasulin Phase II Studies in India
|
|
21 Feb 2007 |
Dyax and Genzyme Announce Agreement to Terminate Joint Venture for the Commercialization of DX-88 in HAE
|
|
17 Feb 2007 |
OrthoLogic Announces Results of Post Hoc Subgroup Analysis of Data From Phase 3 Clinical Trial of Chrysalin (TP508) in Fracture Repair
|
|
16 Feb 2007 |
Stem Cell Sciences and Celogos Sign a Licensing Deal on Autogenous Myoblast Transplantation For Urinary Incontinence Therapy
|
|
16 Feb 2007 |
FDA Accepts ZymoGenetics' Recombinant Human Thrombin Application for Review
|
|
15 Feb 2007 |
Halozyme and Baxter Expand Global HYLENEX Collaboration
|
|
15 Feb 2007 |
Halozyme Therapeutics and Baxter Present Promising Results for the Use of HYLENEX from the Infuse-Morphine Study
|
|
14 Feb 2007 |
Sangart, Inc. Initiates Phase III Clinical Trials
|
|
13 Feb 2007 |
Ambrx Initiates Phase I/II Clinical Trial of Novel Human Growth Hormone Product Candidate
|
|
13 Feb 2007 |
QSV Biologics, Ltd., and Critical Biologics Corp., Sign Contract for cGMP Manufacture of Gelsolin for Critical Care Applications
|
|
09 Feb 2007 |
Zelos Therapeutics' Ostabolin-CTM Increases Bone Mineral Density in Phase 2 Osteoporosis Trial
|
|
09 Feb 2007 |
EU-Approval for Continuous Infusion of KOGENATE(R) Bayer
|
|
09 Feb 2007 |
LAB International Completes Patient Enrollment in Its Growth Hormone Releasing Hormone (GHRH) Product Phase IIA Trial
|
|
09 Feb 2007 |
Amarillo Biosciences Announces Open Enrollment in Its Phase 2 Study of Orally Administered Interferon Alpha in the Treatment of Oral Warts in HIV-Positive Patients
|
